NCT03564483|Recruiting
Gynecologic Extramammary Paget's Disease
Prospective Registry of Gynecologic Patients With Extramammary Paget's Disease
Loading search results
Prospective Registry of Gynecologic Patients With Extramammary Paget's Disease
Sponsor study identifier
observational
100
1 country
1
Study Start
February 19, 2018
Actual (reported)Primary Completion
December 2050
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 2050
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2050
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 19, 2018
Actual (reported)June 11, 2018
Actual (reported)June 20, 2018
Actual (reported)December 2050
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 2050
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Collect prospective data including outcomes and long-term survival in women with extramammary Paget's disease (EMPD).
Prospective data including patient demographic information, surgical outcomes, surgical morbidity, recurrence, and long-term survival in extramammary Paget's disease (EMPD) will be collected as part of this registry..
25 years
All women presenting for evaluation of Extramammary Paget's Disease (EMPD) at Mayo Clinic in Rochester MN.
Women diagnosed with Extramammary Paget's Disease
Mayo Clinic
Rochester, Minnesota, 55905, United States
Bruce KH, Kilts TP, Lohman ME, Vidal NY, Fought AJ, McGree ME, Keeney GL, Baum CL, Brewer JD, Bakkum-Gamez JN, Cliby WA. Mohs surgery for female genital Paget's disease: a prospective observational trial. Am J Obstet Gynecol. 2023 Dec;229(6):660.e1-660.e8. doi: 10.1016/j.ajog.2023.08.018. Epub 2023 Aug 24.
Tumor tissues will be obtained in order to perform tumor molecular profiling to identify targetable somatic mutations in EMPD. The vulvar and perianal microbiome of women with extramammary Paget's disease will be evaluated.
Jamie N. Bakkum-Gamez, M.D.
Mayo Clinic
First Submitted
June 11, 2018
First Posted
June 20, 2018
Study Start
February 19, 2018
Actual (reported)Primary Completion
December 2050
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Contact the study team to confirm eligibility.
Study Completion
December 2050
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
January 28, 2026
Record last verified: 2026-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: